GMP-grade Neural Progenitor Derivation and Differentiation from Clinical-grade Human Embryonic Stem Cells

Overview

Journal Stem Cell Res Ther

Publisher Biomed Central

Date 2020 Sep 19

PMID 32948237

Citations 6

Authors

Loriana Vitillo

Catherine Durance

Zoe Hewitt

Harry Moore

Austin Smith

Ludovic Vallier

Affiliations

Soon will be listed here.

Abstract

Background: A major challenge for the clinical use of human pluripotent stem cells is the development of safe, robust and controlled differentiation protocols. Adaptation of research protocols using reagents designated as research-only to those which are suitable for clinical use, often referred to as good manufacturing practice (GMP) reagents, is a crucial and laborious step in the translational pipeline. However, published protocols to assist this process remain very limited.

Methods: We adapted research-grade protocols for the derivation and differentiation of long-term neuroepithelial stem cell progenitors (lt-NES) to GMP-grade reagents and factors suitable for clinical applications. We screened the robustness of the protocol with six clinical-grade hESC lines deposited in the UK Stem Cell Bank.

Results: Here, we present a new GMP-compliant protocol to derive lt-NES, which are multipotent, bankable and karyotypically stable. This protocol resulted in robust and reproducible differentiation of several clinical-grade embryonic stem cells from which we derived lt-NES. Furthermore, GMP-derived lt-NES demonstrated a high neurogenic potential while retaining the ability to be redirected to several neuronal sub-types.

Conclusions: Overall, we report the feasibility of derivation and differentiation of clinical-grade embryonic stem cell lines into lt-NES under GMP-compliant conditions. Our protocols could be used as a flexible tool to speed up translation-to-clinic of pluripotent stem cells for a variety of neurological therapies or regenerative medicine studies.

Citing Articles

Human iPSC-derived neural stem cells displaying radial glia signature exhibit long-term safety in mice.

Luciani M, Garsia C, Beretta S, Cifola I, Peano C, Merelli I Nat Commun. 2024; 15(1):9433.

PMID: 39487141 PMC: 11530573. DOI: 10.1038/s41467-024-53613-7.

In Vivo Tumorigenicity of the 20q11.21 Amplicon in an Engraftment Model of hPSCs and Differentiated Liver Cells.

Pridgeon C, Forootan S, Zhang F, Harper N, Palmer D, Weightmann R J Stem Cells Regen Med. 2023; 19(1):3-13.

PMID: 37366409 PMC: 10290816. DOI: 10.46582/jsrm.1901002.

Xeno-free induced pluripotent stem cell-derived neural progenitor cells for in vivo applications.

Rust R, Weber R, Generali M, Kehl D, Bodenmann C, Uhr D J Transl Med. 2022; 20(1):421.

PMID: 36114512 PMC: 9482172. DOI: 10.1186/s12967-022-03610-5.

Cell Membrane-Coated Mimics: A Methodological Approach for Fabrication, Characterization for Therapeutic Applications, and Challenges for Clinical Translation.

Chugh V, Vijaya Krishna K, Pandit A ACS Nano. 2021; 15(11):17080-17123.

PMID: 34699181 PMC: 8613911. DOI: 10.1021/acsnano.1c03800.

Recent trends in stem cell-based therapies and applications of artificial intelligence in regenerative medicine.

Mukherjee S, Yadav G, Kumar R World J Stem Cells. 2021; 13(6):521-541.

PMID: 34249226 PMC: 8246250. DOI: 10.4252/wjsc.v13.i6.521.

References

Jacquet L, Stephenson E, Collins R, Patel H, Trussler J, Al-Bedaery R . Strategy for the creation of clinical grade hESC line banks that HLA-match a target population. EMBO Mol Med. 2012; 5(1):10-7. PMC: 3569650. DOI: 10.1002/emmm.201201973. View

Thomson J, Itskovitz-Eldor J, Shapiro S, Waknitz M, Swiergiel J, Marshall V . Embryonic stem cell lines derived from human blastocysts. Science. 1998; 282(5391):1145-7. DOI: 10.1126/science.282.5391.1145. View

Abbasalizadeh S, Baharvand H . Technological progress and challenges towards cGMP manufacturing of human pluripotent stem cells based therapeutic products for allogeneic and autologous cell therapies. Biotechnol Adv. 2013; 31(8):1600-23. DOI: 10.1016/j.biotechadv.2013.08.009. View

Huang M, Tailor J, Zhen Q, Gillmor A, Miller M, Weishaupt H . Engineering Genetic Predisposition in Human Neuroepithelial Stem Cells Recapitulates Medulloblastoma Tumorigenesis. Cell Stem Cell. 2019; 25(3):433-446.e7. PMC: 6731167. DOI: 10.1016/j.stem.2019.05.013. View

Hewitt Z, Amps K, Moore H . Derivation of GMP raw materials for use in regenerative medicine: hESC-based therapies, progress toward clinical application. Clin Pharmacol Ther. 2007; 82(4):448-52. DOI: 10.1038/sj.clpt.6100321. View

Wang J, Hao J, Bai D, Gu Q, Han W, Wang L . Generation of clinical-grade human induced pluripotent stem cells in Xeno-free conditions. Stem Cell Res Ther. 2015; 6:223. PMC: 4643509. DOI: 10.1186/s13287-015-0206-y. View

Falk A, Koch P, Kesavan J, Takashima Y, Ladewig J, Alexander M . Capture of neuroepithelial-like stem cells from pluripotent stem cells provides a versatile system for in vitro production of human neurons. PLoS One. 2012; 7(1):e29597. PMC: 3260177. DOI: 10.1371/journal.pone.0029597. View

Tailor J, Kittappa R, Leto K, Gates M, Borel M, Paulsen O . Stem cells expanded from the human embryonic hindbrain stably retain regional specification and high neurogenic potency. J Neurosci. 2013; 33(30):12407-22. PMC: 3721847. DOI: 10.1523/JNEUROSCI.0130-13.2013. View

Koch P, Opitz T, Steinbeck J, Ladewig J, Brustle O . A rosette-type, self-renewing human ES cell-derived neural stem cell with potential for in vitro instruction and synaptic integration. Proc Natl Acad Sci U S A. 2009; 106(9):3225-30. PMC: 2651316. DOI: 10.1073/pnas.0808387106. View

10.

Solomon J, Csontos L, Clarke D, Bonyhadi M, Zylberberg C, McNiece I . Current perspectives on the use of ancillary materials for the manufacture of cellular therapies. Cytotherapy. 2015; 18(1):1-12. DOI: 10.1016/j.jcyt.2015.09.010. View

11.

Trounson A, McDonald C . Stem Cell Therapies in Clinical Trials: Progress and Challenges. Cell Stem Cell. 2015; 17(1):11-22. DOI: 10.1016/j.stem.2015.06.007. View

12.

Stacey G, Andrews P, Asante C, Barbaric I, Barry J, Bisset L . Science-based assessment of source materials for cell-based medicines: report of a stakeholders workshop. Regen Med. 2018; 13(8):935-944. DOI: 10.2217/rme-2018-0120. View

13.

Cahan P, Daley G . Origins and implications of pluripotent stem cell variability and heterogeneity. Nat Rev Mol Cell Biol. 2013; 14(6):357-68. PMC: 3980962. DOI: 10.1038/nrm3584. View

14.

Nakagawa M, Taniguchi Y, Senda S, Takizawa N, Ichisaka T, Asano K . A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells. Sci Rep. 2014; 4:3594. PMC: 3884228. DOI: 10.1038/srep03594. View

15.

Takahashi K, Yamanaka S . Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126(4):663-76. DOI: 10.1016/j.cell.2006.07.024. View

16.

Whiting P, Kerby J, Coffey P, da Cruz L, McKernan R . Progressing a human embryonic stem-cell-based regenerative medicine therapy towards the clinic. Philos Trans R Soc Lond B Biol Sci. 2015; 370(1680):20140375. PMC: 4634002. DOI: 10.1098/rstb.2014.0375. View

17.

Chen G, Gulbranson D, Hou Z, Bolin J, Ruotti V, Probasco M . Chemically defined conditions for human iPSC derivation and culture. Nat Methods. 2011; 8(5):424-9. PMC: 3084903. DOI: 10.1038/nmeth.1593. View

18.

Ratcliffe E, Glen K, Naing M, Williams D . Current status and perspectives on stem cell-based therapies undergoing clinical trials for regenerative medicine: case studies. Br Med Bull. 2013; 108:73-94. DOI: 10.1093/bmb/ldt034. View

19.

Lundin A, Delsing L, Clausen M, Ricchiuto P, Sanchez J, Sabirsh A . Human iPS-Derived Astroglia from a Stable Neural Precursor State Show Improved Functionality Compared with Conventional Astrocytic Models. Stem Cell Reports. 2018; 10(3):1030-1045. PMC: 5918339. DOI: 10.1016/j.stemcr.2018.01.021. View

20.

Williams D, Archer R, Archibald P, Bantounas I, Baptista R, Barker R . Comparability: manufacturing, characterization and controls, report of a UK Regenerative Medicine Platform Pluripotent Stem Cell Platform Workshop, Trinity Hall, Cambridge, 14-15 September 2015. Regen Med. 2016; 11(5):483-92. PMC: 5422032. DOI: 10.2217/rme-2016-0053. View